Tala Shekarkhand

Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Ola Landgren, Malin Hultcrantz, Benjamin Diamond et al. · JAMA Oncology · 2021 · 120 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

Urvi A. Shah, Kylee Maclachlan, Andriy Derkach et al. · Clinical Cancer Research · 2022 · 49 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +17

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Ross Firestone, Devin McAvoy, Tala Shekarkhand et al. · Blood Advances · 2023 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma

Ross Firestone, Nicholas D. Socci, Tala Shekarkhand et al. · Blood · 2024 · 49 citations · Full text

Life Sciences, Immunology, Oncology +15

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

Karthik Nath, Tala Shekarkhand, David Nemirovsky et al. · Blood Cancer Journal · 2024 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17